Financial Data and Key Metrics Changes - Revenue for Q2 2025 increased by 20.3% year over year to $278.2 million, and by 62.6% compared to 2023 [5][24] - Same restaurant sales grew by 2.1%, primarily driven by menu price and product mix, with guest traffic remaining approximately flat [24] - Adjusted EBITDA for the quarter was $42.1 million, reflecting a 22.6% increase compared to 2024 [29] - Net income for the quarter was $18.4 million, compared to $16.8 million in 2024, with diluted EPS at $0.16 [30] Business Line Data and Key Metrics Changes - The company opened 16 net new restaurants, bringing the total to 398 locations across 27 states and the District of Columbia [5][24] - Restaurant level profit margin was 26.3%, slightly down from 26.5% in 2024, but reflecting a 19.6% increase in dollar terms [26] - New restaurant productivity was approximately 109%, exceeding the target of $2.3 million in average unit volumes [26] Market Data and Key Metrics Changes - The Mediterranean cuisine category continues to show strength, with a three-year traffic growth of 19.7% and increasing market share [32] - The company is expanding into new markets, including Pittsburgh and Michigan, with positive reception from customers [8][9] Company Strategy and Development Direction - The company aims to reach at least 1,000 restaurants by February 2032, focusing on expanding its Mediterranean concept [9][32] - The "Project Soul" initiative is designed to enhance the guest experience through inviting restaurant designs [9] - The company is committed to culinary innovation, with new menu items like chicken shawarma and cinnamon sugar pita chips being tested and rolled out [10][11] Management's Comments on Operating Environment and Future Outlook - Management acknowledged macroeconomic pressures but expressed confidence in the long-term trajectory and structural strength of the business [5][32] - The company is seeing a reacceleration in same restaurant sales as it moves into Q3, driven by strong demand for Mediterranean cuisine [25][32] - Management emphasized the importance of maintaining operational excellence and enhancing guest experiences as the company scales [15][18] Other Important Information - The company has zero debt and $385.8 million in investments, with access to a $75 million undrawn revolver [31] - The effective tax rate for Q2 was 22.5%, with expectations for the full year to be between 12-15% [30] Q&A Session Summary Question: Could you elaborate on the same store sales side? - Management noted that macro pressures are present but emphasized the strong performance of the 2024 restaurant class, which exceeded expectations [35][38] Question: Can you help level set where you're trending in the third quarter? - Management indicated that the trend is continuing to improve, with acceleration in same restaurant sales [42] Question: Has the company evaluated its marketing media mix? - Management acknowledged the opportunity to increase marketing spend as awareness grows in new markets, while maintaining a long-term strategic focus [44][46] Question: Does the honeymoon period mean first year comps are negative? - Management confirmed that while some restaurants in the 2024 class are delivering strong results, they are impacting same restaurant sales due to the honeymoon effect [48][53] Question: What do you attribute to the July improvement? - Management attributed the improvement to the end of the steak launch lap and enhancements in guest experience [67][69] Question: Can you talk about the assistant manager edition? - Management explained that the rollout will begin in November, aimed at strengthening leadership and operational support in high-volume restaurants [72][75] Question: Can you talk about the 2Q mix? - Management stated that there were no significant changes in mix, and chicken shawarma will be priced at a premium compared to other chicken items [78][79] Question: What marketing opportunities could open now that you've crossed $1 billion in sales? - Management indicated that achieving this milestone allows for more effective marketing strategies and leveraging investments across scaled markets [82][85]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $15.6 million, in line with guidance, but represented a 5% year-over-year decline and a sequential decline due to lower production volume estimates and the wind down of non-core data contracts [21][14][22] - Gross loss for the quarter was $12.4 million on a GAAP basis and $10.8 million on a non-GAAP basis, which was worse than the guidance of negative $5 million to $10 million [23] - Operating expenses (OpEx) were $27 million on a GAAP basis and $47 million on a non-GAAP basis, with expectations to reduce non-GAAP OpEx to the low $30 million range by Q4 2025 [24][29] Business Line Data and Key Metrics Changes - The company shipped approximately 5,000 Iris sensors in Q2, down from 6,000 in Q1, primarily due to lower demand from Volvo [22] - The decision to exit non-core initiatives, including data and insurance businesses, is expected to reduce operating expenses by nearly $23 million annually starting in 2026 [11][29] Market Data and Key Metrics Changes - The automotive market is seeing a shift towards incorporating autonomous driving and advanced safety features, with Luminar working with leading OEMs like Volvo, Nissan, and Mercedes [5] - The company is focusing on commercial markets such as trucking, security, and defense, where unit economics are more attractive and autonomy is advancing quickly [7][8] Company Strategy and Development Direction - Luminar is aligning its strategy to focus on execution and operational discipline, aiming to strengthen its balance sheet and reduce cash burn [4][13] - The HALO platform is seen as key to broader LiDAR adoption, with ongoing development programs with OEM partners [7] - The company is transitioning production from Mexico to Thailand to improve unit economics and streamline operations [12] Management's Comments on Operating Environment and Future Outlook - Management acknowledged that the widespread adoption of Level 3 and higher autonomy is progressing more slowly than expected, prompting a shift in focus to near-term revenue opportunities [7] - The company has revised its 2025 revenue guidance down to $67 million to $74 million, primarily due to lower sensor shipment expectations and the wind down of non-core contracts [27] Other Important Information - The company secured a $200 million convertible preferred facility to strengthen liquidity and extend its runway, with plans to reduce the outstanding balance of 2026 convertible notes to below $100 million by year-end [20][21] - The company expects to end fiscal year 2025 with $80 million to $100 million in cash and marketable securities, slightly below previous expectations [30] Q&A Session Summary Question: Size of opportunities in adjacent markets - Management indicated that the commercial markets are very large but did not provide specific sizes, stating that customer information will be shared in future calls [35] Question: Shipment of sensors at unfavorable economics - Management explained that lower than expected volumes have led to unfavorable sensor economics, with actions being taken to close the gap [38] Question: Revenue realization from commercial markets - Management confirmed that revenues are being realized today and expect growth in 2026, but did not provide specific forecasts [42] Question: Non-GAAP OpEx funding adjacent opportunities - Management stated that the investments in adjacent opportunities are consistent with the OpEx target mentioned [43] Question: Focus on ADAS vs. robotaxis in the automotive market - Management clarified that while Luminar is focused on higher levels of autonomy within passenger vehicles, the timing of progression is uncertain, leading to a focus on other market opportunities [45] Question: Downside revision to full year revenue guidance - Management explained that about two-thirds of the $15 million reduction in guidance is related to lower sensor shipments, with the remainder attributed to the wind down of the non-core data contract [49] Question: Update on partnership with Mercedes Benz - Management confirmed a development agreement with Mercedes and expressed hope to convert it into a production agreement based on milestone achievements [52]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was approximately $9.1 million, a 0.4% increase compared to the same quarter in 2024, excluding $800,000 from divested operations [4][5] - Managed services revenue increased by 12.9% when excluding the divested Hozu operations [5] - Net income for Q2 2025 was $1.2 million or $0.07 per share, compared to a net loss of $2.2 million or negative $0.13 per share in Q2 2024 [9][10] - Adjusted EBITDA for Q2 2025 was $1.3 million, a significant improvement from a negative $2.2 million in the prior year [9][10] Business Line Data and Key Metrics Changes - Managed services bookings for Q2 2025 totaled $5.6 million, bringing total bookings for the year to date to $13.1 million, compared to $9.6 million in the same period of 2024 [5][6] - The decline in bookings was attributed to timing differences, a strategic shift towards larger accounts, and macroeconomic pressures affecting marketing budgets [6] Market Data and Key Metrics Changes - As of June 30, 2025, managed services backlog was $11.5 million, representing unrecognized revenue from ongoing contracts [7] - Total cost of revenue was $4.4 million, or 48% of revenue, down from 57% in the prior year [8] Company Strategy and Development Direction - The company has committed to a business model focused on higher growth and profitability, reducing international exposure and emphasizing larger, recurring accounts [14][15] - New business was secured from notable clients such as Jeep, Nestle, and Kellogg's, indicating a strong sales pipeline [15] - A new technology initiative was launched to enhance campaign management and integrate more AI into business processes [15] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, citing a strong pipeline and the addition of large customers as key growth drivers [16][33] - The company is strategically preparing for M&A opportunities while ensuring integration readiness [21][22] Other Important Information - The company has no debt and maintains a cash and investment balance of $50.6 million, positioning it well for organic growth and acquisitions [11] - Operating cash flow is positive, covering approximately half of the stock repurchase program investments [10][11] Q&A Session Summary Question: Can you elaborate on M&A activity? - Management confirmed they are actively engaging in discussions for potential M&A, emphasizing a strategic and responsible approach to capital use [21][22] Question: What about valuations in the private markets? - Management stated they will be reasonable and not overpay for acquisitions, aiming for mutually beneficial deals [24] Question: Can you discuss the decline in bookings and future revenue growth? - Management explained the decline was due to timing issues, a shift towards more profitable accounts, and macroeconomic factors, but expressed confidence in the long-term success of the new model [26][27] Question: What are the expectations for operating expenses going forward? - Management indicated that operating expenses are expected to remain flat, with some efficiencies allowing for growth without proportional cost increases [29][30] Question: Is there any revenue guidance for the remainder of the year? - Management refrained from providing specific revenue guidance but noted a strong pipeline and relationships with large customers [32][33] Question: Is the new VP of Talent Acquisition a full-time position? - Management confirmed that the new VP is full-time and will focus on attracting talent across various areas, not just marketing [34]

Financial Data and Key Metrics Changes - The company reported net sales for YUPELRI of approximately $66 million for the quarter, representing a 22% year-over-year increase, marking the highest Q2 results since launch [4][8] - Collaboration revenue grew by 31% year-over-year, driven by YUPELRI's net sales growth, leading to improved brand-level profit margins [22][24] - Non-GAAP losses improved to $4.2 million compared to $6.3 million in the prior year, excluding one-time items [25] Business Line Data and Key Metrics Changes - YUPELRI's hospital channel volume increased by 31% compared to 2024, with a long-acting nebulized market share in hospitals reaching approximately 20% [10][11] - The company completed the $225 million sale of its remaining royalty interest in Trelegy to GSK, significantly strengthening its balance sheet [4][22] - Ampreloxetine's Phase 3 Cyprus trial is nearing completion of enrollment, with expectations to report top-line data approximately six months after [5][28] Market Data and Key Metrics Changes - YUPELRI received approval in China, triggering a $7.5 million milestone payment, with plans for commercialization led by Beatrice [4][11] - GSK reported an all-time high of $1.1 billion in Trelegy sales for Q2, contributing to a year-to-date sales total of approximately $2 billion, an 8% increase year-over-year [22] Company Strategy and Development Direction - The company is focused on enhancing shareholder value through strategic reviews and disciplined capital management [6][28] - Ampreloxetine is positioned as a potential transformative therapy for patients with multiple system atrophy (MSA), with a targeted addressable population of approximately 40,000 patients in the U.S. [21][28] - The company aims to maintain a strong financial position while preparing for the upcoming data readout from the Cyprus study [28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving the $250 million sales threshold for YUPELRI, which would trigger a $25 million milestone payment [9][10] - The company anticipates a stronger second half of the year compared to previous expectations, creating a solid financial foundation as it approaches the Cyprus data readout [26][28] - Management highlighted the importance of the upcoming Cyprus trial results, which could redefine the standard of care for patients with MSA [28] Other Important Information - The company ended the quarter with approximately $340 million in cash and no debt, indicating strong cash management [6][25] - The company is preparing for NDA readiness in parallel with the Cyprus study, with modules already in advanced stages of drafting [19] Q&A Session Summary Question: What contributed to the improved pull-through for YUPELRI this quarter? - Management attributed the improved pull-through to the shift of volume to specialty pharmacy, which enhances patient support and fulfillment [32][35] Question: What is the outlook for YUPELRI in China and the enrollment trends for Cyprus? - Management noted that Beatrice will lead the commercialization in China, and the enrollment profile for Cyprus is expected to be similar to previous studies [41][42] Question: How will pricing for Ampreloxetine be determined? - Management indicated that while it is early to finalize pricing, analysis of recent rare neuro drug launches suggests an average price around $380,000 per year [47] Question: What are the expectations for SG&A increases associated with Ampreloxetine? - Management expects SG&A to remain stable through the second half of the year, with potential increases post-data readout if results are positive [54][56]

Sky Harbour Group (SKYH) Q2 2025 Earnings Call August 12, 2025 05:00 PM ET Speaker0Good afternoon. My name is Sarah, and I will be your conference operator today. At this time, I would like to welcome everyone to the Sky Harbor Second Quarter twenty twenty five Earnings Call and Webinar. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session.Thank you. I would now like to turn the call to CFO, Francisco Gonzalez. You may b ...

Financial Data and Key Metrics Changes - Revenue for Q2 2025 grew 207% year over year to $1,200,000,000, marking the first quarter with both $1,000,000,000 in revenue and $200,000,000 in adjusted operating income [5][21] - Adjusted operating income for Q2 was $200,000,000, with an adjusted operating income margin of 16% [22] - Net loss for the quarter was $291,000,000, an improvement from a net loss of $323,000,000 in Q2 2024 [23] - Adjusted EBITDA for Q2 was $753,000,000, scaling more than 3x year over year, with an adjusted EBITDA margin of 62% [24] - Capital expenditures (CapEx) in Q2 totaled $2,900,000,000, up over $1,000,000,000 quarter over quarter [25] Business Line Data and Key Metrics Changes - The company ended Q2 with $30,100,000,000 in contracted backlog, up $4,000,000,000 from Q1 and doubling year to date [6][21] - Significant growth was noted in the VFX cloud service product, with a fourfold increase in usage [7] - Expansion contracts were signed with both hyperscale customers, indicating strong demand across various sectors [20] Market Data and Key Metrics Changes - The company is experiencing unprecedented demand for AI cloud services, with a structurally undersupplied market [5][20] - Increased adoption in sectors such as healthcare, finance, and media is driving demand for specialized cloud infrastructure [9][10] - The company is expanding its footprint to meet intensifying demand signals from customers [6] Company Strategy and Development Direction - CoreWeave is focused on vertical integration to enhance operational efficiencies and reduce costs, exemplified by the proposed acquisition of Core Scientific [16][18] - The company aims to scale its infrastructure rapidly to meet customer demand, with plans to deliver over 900 megawatts of active power by year-end [6][31] - Investments in data center infrastructure are being prioritized to support growth and meet the evolving needs of customers [15][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued strong demand for AI services, despite a structurally supply-constrained environment [20][29] - The company anticipates Q3 revenue in the range of $1,260,000,000 to $1,300,000,000, with adjusted operating income between $160,000,000 to $190,000,000 [29][30] - Full-year revenue guidance has been raised to a range of $5,150,000,000 to $5,350,000, driven by ongoing strong customer demand [31] Other Important Information - The company has successfully raised $6,400,000,000 in the capital markets, reducing its cost of capital [20][27] - A new flexible capacity product is being introduced to help customers manage demand more effectively [12] Q&A Session Summary Question: Renewal of hyperscaler contracts and achieving better return on assets - Management focuses on expansion rather than renewals, indicating confidence in continued business with hyperscaler clients [40][41] - Cost savings and operational efficiencies are being pursued through acquisitions and disciplined scaling [42][43] Question: Demand and supply dynamics - The company is experiencing significant demand for both training and inference workloads, with supply constraints primarily at the power level [47][51] - Management maintains that the market is structurally supply constrained, impacting the ability to meet demand [68] Question: Government interest in AI data centers - Various governments are exploring partnerships for AI infrastructure, with differing levels of openness to US-based providers [56][57] Question: Backlog figures and future expectations - The $30,100,000,000 backlog reflects significant demand, with large contracts expected to move the needle in the future [84][85] Question: Repurposing older GPU clusters - Older GPU clusters are being successfully recontracted for additional terms, primarily for inference workloads [88] Question: CapEx timing and cost implications - CapEx is expected to ramp up in Q4, with costs incurred ahead of revenue generation due to infrastructure deployment [96][98]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $11.7 million, an increase from $11.4 million in Q1 2025, driven by new sales and upsells despite some offsets due to migration activities to the new Marchex Engage platform [9] - Cash increased to $10.5 million from $10 million at the end of Q1 2025, with expectations for stable to favorable cash balances in Q3 2025 [10] - The company reported positive net income of approximately $100,000 for Q2 2025 [10] Business Line Data and Key Metrics Changes - The company launched the Marchex Engage platform, which is expected to drive future growth through new user interfaces and AI solutions [4][5] - The Engage platform integrates AI-driven conversation intelligence, focusing on vertical markets such as automotive, healthcare, and home services [5][6] Market Data and Key Metrics Changes - The company noted that new federal tariffs on imports have adversely impacted various industries, including automotive and auto services, creating increased uncertainty in the market [11] - The current macroeconomic environment has also introduced challenges, affecting customer behavior and revenue predictability [11] Company Strategy and Development Direction - Marchex is focused on expanding its market opportunities through partnerships with Fortune 500 companies and launching innovative products [4][6] - The company aims to leverage first-party data and AI insights to enhance customer engagement and drive measurable outcomes [6][7] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by migration activities and macroeconomic factors, which may delay achieving annual revenue and adjusted EBITDA goals for 2025 [11][12] - Despite these challenges, the leadership team remains optimistic about executing their strategic plan and believes they are well-positioned for future growth [13] Other Important Information - The company anticipates that both revenue and adjusted EBITDA will sequentially increase in Q3 2025 compared to Q2 2025, with adjusted EBITDA potentially increasing by more than 50% [10] - The migration to the new Engage platform is mostly completed, but it has short-term revenue impacts due to timing and product utilization [11] Q&A Session Summary Question: Did bookings improve sequentially in the second quarter? - Management confirmed that sales or ACV was sequentially higher [18] Question: Any comments on the pipeline? - Management highlighted the progress with the Engage platform and upcoming product launches, which are expected to drive growth [19][20] Question: How is the demand for your service use case versus sales? - Management noted increasing average revenue per sale associated with the Engage platform and expressed excitement about expanding channel opportunities [23][24]

Lumentum (LITE) Q4 2025 Earnings Call August 12, 2025 05:00 PM ET Speaker0Good day, everyone, and welcome to the Lumentum Holdings Fourth Quarter Fiscal Year twenty twenty five Earnings Call. All participants will be in a listen only mode. Please also note today's event is being recorded for replay purposes. Session. At this time, I would like to turn the conference call over to Kathy Ta, Vice President of Investor Relations.Ms. Ta, please go ahead.Speaker1Thank you, Reagan, and welcome to Lumentum's fiscal ...

CXApp (CXAI) Q2 2025 Earnings Call August 12, 2025 05:00 PM ET Speaker0Greetings. Welcome to the CXAI second quarter two thousand twenty five earnings call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference call is being recorded.Now I would like to turn the call over to your host, Karam Sheikh, chairman and CEO of CXAI. Please go ahead.Speaker1Thank you, operator. Good afternoon, everybody. I'm joined ...

KinderCare Learning Companies (KLC) Q2 2025 Earnings Call August 12, 2025 05:00 PM ET Speaker0Good afternoon, ladies and gentlemen, and welcome to the KinderCare Second Quarter twenty twenty five Earnings Conference Call. At this time, all lines are in a listen only mode. Following the presentation, we will conduct a question and answer session. This call is being recorded on Tuesday, 08/12/2025. I would now like to turn the conference over to Ms.Olivia Keer, Vice President of Investor Relations. Please go ...